Clinical Trial Update: Head-to-head Comparison of 68Ga-PSMA-11 and 18F-PSMA-1007 [NA]

View source ↗

Summary

This clinical trial update reports a head-to-head comparison of two PSMA-targeted imaging tracers, 68Ga-PSMA-11 and 18F-PSMA-1007, in prostate cancer, and notes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 18F-PSMA-1007 (PSMA-1007 radiotracer)
• 68Ga-PSMA-11 (Gallium-68 labeled PSMA-11 radiopharmaceutical)

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Prostate Cancer | NA | Status: COMPLETED